Dr. Divenuti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
250 Pleasant St
Concord, NH 03301Phone+1 603-622-6484Fax+1 603-622-7438
Education & Training
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 2000 - 2003- Tufts Medical CenterResidency, Internal Medicine, 1997 - 2000
The Warren Alpert Medical School of Brown UniversityClass of 1997
Certifications & Licensure
MA State Medical License 2001 - 2026
NH State Medical License 2003 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2014
Publications & Presentations
PubMed
- 74 citationsA phase-1 trial of bexarotene and denileukin diftitox in patients with relapsed or refractory cutaneous T-cell lymphoma.Francine M. Foss, Gina DiVenuti
Blood. 2005-07-15 - 143 citationsProspective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and surv...Francine M. Foss, Gina DiVenuti, Kevin M. Chin, Kellie Sprague, H Grodman
Bone Marrow Transplantation. 2005-06-01 - 17 citationsDenileukin Diftitox and Hyper-CVAD in the Treatment Human T-Cell Lymphotropic Virus 1–Associated Adult T-Cell Leukemia/LymphomaGina DiVenuti, Rangana Nawgiri, Francine M. Foss
Clinical Lymphoma. 2003-12-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
